We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

MorphoSys Presents Updated Phase 2 Clinical Results for MOR208

News   Jun 04, 2015

 
MorphoSys Presents Updated Phase 2 Clinical Results for MOR208
 
 
 

RELATED ARTICLES

Precise Measuring Tool for Optimal Antibody Effectiveness

News

Using DNA origami scientists have been able to demonstrate the most accurate distance between densely packed antigens in order to get the strongest bond to antibodies in the immune system.

READ MORE

Costs and Complications of Lung Cancer Diagnostic Tests Underestimated

News

This study underscores the importance of sharing risks with patients considering lung cancer screening.

READ MORE

Osteoarthritis Stem Cell Therapy Success in Phase I and II Trials

News

Details of a new therapy for the symptomatic treatment of osteoarthritis have been revealed, using mesenchymal cells from umbilical cord stroma.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE